Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,896.00
+2.00 (0.11%)
Jan 22, 2026, 3:30 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 346.76 billion as of January 22, 2026. Its market cap has decreased by -0.58% in one year.
Market Cap
346.76B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
35.45
Stock Price
1,896.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 346.76B, an increase of 461.08%. That is a compound annual growth rate of 5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 346.76B | -5.20% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong-A ST | 465.26B |
| Humedix | 419.00B |
| EuBiologics | 416.23B |
| Bukwang Pharmaceutical | 375.91B |
| Hyundai Pharmaceutical | 364.52B |
| BNC Korea | 323.51B |
| Huons | 302.36B |
| CMG Pharmaceutical | 279.42B |